1-4 of 4
N Villamor
Close
Sort by
Journal Articles

Combination Chemotherapy with Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) Induces a High Response Rate in Previously Untreated CLL.

Francesc Bosch, A. Ferrer, N. Villamor, E. Gine, M.A. Abella, S. Gardella, J. Besalduch, M. Gonzalez, A. Altes, L. Escoda, S. Ferrer, E. Gonzalez-Barca, E. Perez-Ceballos, A. Asensi, E. Montserrat
Journal: Blood
Blood (2005) 106 (11): 718.
https://doi.org/10.1182/blood.V106.11.718.718
Published: 2005
Journal Articles

International Standardized Approach to Molecular and Flow Cytometric Residual Disease Monitoring in CLL.

A. C. Rawstron, N. Villamor, J. L. Zehnder, P. Ghia, M. Ritgen, S. Bottcher, G. Lozanski, A. P. Mone, D. Colomer, C. Moreno, M. Geuna, P. A. Evans, M. Kneba, Y. Natkunam, S. E. Coutre, F. Caligaris-Cappio, M. J. Hallek, J. C. Byrd, E. Montserrat, P. Hillmen
Journal: Blood
Blood (2004) 104 (11): 15.
https://doi.org/10.1182/blood.V104.11.15.15
Published: 2004
Journal Articles

PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma

F Bosch, P Jares, E Campo, A Lopez-Guillermo, MA Piris, N Villamor, D Tassies, ES Jaffe, E Montserrat, C Rozman
Journal: Blood
Blood (1994) 84 (8): 2726–2732.
https://doi.org/10.1182/blood.V84.8.2726.2726
Published: 1994
Journal Articles

CD11c positive B-chronic lymphocytic leukemia [letter]

D Tassies, E Montserrat, N Villamor, C Rozman
Journal: Blood
Blood (1991) 78 (7): 1893.
https://doi.org/10.1182/blood.V78.7.1893a.1893a
Published: 1991